Prediction model for mortality after intracranial hemorrhage in patients with leukemia

Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, Jianqin Shan, Farhad Ravandi, Jorge Cortes, Jeffrey Weinberg, Elias Jabbour, Stefan Faderl, William Wierda, Deborah Thomas, Susan O'Brien, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journalArticle

Abstract

Intracranial hemorrhage (ICH) is associated with great morbidity and mortality in patients with acute leukemia. We identified 118 patients with ICH from a total of 2,421 patient with leukemia who were treated at our institution between 2005-2009, and assessed the prognostic factors for mortality in the ICH cohort. Median age at time of ICH was 58 years, 49% were male, and 60% had acute myeloid leukemia. The relative incidence of ICH was highest in patients with chronic myeloid leukemia in blast crisis (12.1%). Mental status changes were the most common symptom which prompted work-up for ICH. Median survival for all patients after onset of ICH was 20 days. In multivariate analyses, four clinical characteristics were identified as independent adverse factors for mortality in patients with ICH: albumin <3.5 g/dL, lactate dehydrogenase (LDH) >835 U/L, age > 60 years, and relapsed disease status. Based on the number of risk factors, mortality after ICH was: 25% (0 risk factor), 47% (1), 78% (2), and >97% (3 or 4). In conclusion, patients with leukemia who develop ICH do not have universally poor outcomes, and a simple scoring system could serve to advise physicians and families of the prognosis and the potential benefit of aggressive treatment options.

Original languageEnglish (US)
Pages (from-to)546-549
Number of pages4
JournalAmerican Journal of Hematology
Volume86
Issue number7
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Intracranial Hemorrhages
Leukemia
Mortality
Blast Crisis
Family Physicians
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Acute Myeloid Leukemia
Albumins
Multivariate Analysis
Morbidity
Survival

ASJC Scopus subject areas

  • Hematology

Cite this

Dayyani, F., Mougalian, S. S., Naqvi, K., Shan, J., Ravandi, F., Cortes, J., ... Garcia-Manero, G. (2011). Prediction model for mortality after intracranial hemorrhage in patients with leukemia. American Journal of Hematology, 86(7), 546-549. https://doi.org/10.1002/ajh.22031

Prediction model for mortality after intracranial hemorrhage in patients with leukemia. / Dayyani, Farshid; Mougalian, Sarah Schellhorn; Naqvi, Kiran; Shan, Jianqin; Ravandi, Farhad; Cortes, Jorge; Weinberg, Jeffrey; Jabbour, Elias; Faderl, Stefan; Wierda, William; Thomas, Deborah; O'Brien, Susan; Pierce, Sherry; Kantarjian, Hagop; Garcia-Manero, Guillermo.

In: American Journal of Hematology, Vol. 86, No. 7, 01.07.2011, p. 546-549.

Research output: Contribution to journalArticle

Dayyani, F, Mougalian, SS, Naqvi, K, Shan, J, Ravandi, F, Cortes, J, Weinberg, J, Jabbour, E, Faderl, S, Wierda, W, Thomas, D, O'Brien, S, Pierce, S, Kantarjian, H & Garcia-Manero, G 2011, 'Prediction model for mortality after intracranial hemorrhage in patients with leukemia', American Journal of Hematology, vol. 86, no. 7, pp. 546-549. https://doi.org/10.1002/ajh.22031
Dayyani, Farshid ; Mougalian, Sarah Schellhorn ; Naqvi, Kiran ; Shan, Jianqin ; Ravandi, Farhad ; Cortes, Jorge ; Weinberg, Jeffrey ; Jabbour, Elias ; Faderl, Stefan ; Wierda, William ; Thomas, Deborah ; O'Brien, Susan ; Pierce, Sherry ; Kantarjian, Hagop ; Garcia-Manero, Guillermo. / Prediction model for mortality after intracranial hemorrhage in patients with leukemia. In: American Journal of Hematology. 2011 ; Vol. 86, No. 7. pp. 546-549.
@article{f5777d196a6643619cb8cd835fcf0f06,
title = "Prediction model for mortality after intracranial hemorrhage in patients with leukemia",
abstract = "Intracranial hemorrhage (ICH) is associated with great morbidity and mortality in patients with acute leukemia. We identified 118 patients with ICH from a total of 2,421 patient with leukemia who were treated at our institution between 2005-2009, and assessed the prognostic factors for mortality in the ICH cohort. Median age at time of ICH was 58 years, 49{\%} were male, and 60{\%} had acute myeloid leukemia. The relative incidence of ICH was highest in patients with chronic myeloid leukemia in blast crisis (12.1{\%}). Mental status changes were the most common symptom which prompted work-up for ICH. Median survival for all patients after onset of ICH was 20 days. In multivariate analyses, four clinical characteristics were identified as independent adverse factors for mortality in patients with ICH: albumin <3.5 g/dL, lactate dehydrogenase (LDH) >835 U/L, age > 60 years, and relapsed disease status. Based on the number of risk factors, mortality after ICH was: 25{\%} (0 risk factor), 47{\%} (1), 78{\%} (2), and >97{\%} (3 or 4). In conclusion, patients with leukemia who develop ICH do not have universally poor outcomes, and a simple scoring system could serve to advise physicians and families of the prognosis and the potential benefit of aggressive treatment options.",
author = "Farshid Dayyani and Mougalian, {Sarah Schellhorn} and Kiran Naqvi and Jianqin Shan and Farhad Ravandi and Jorge Cortes and Jeffrey Weinberg and Elias Jabbour and Stefan Faderl and William Wierda and Deborah Thomas and Susan O'Brien and Sherry Pierce and Hagop Kantarjian and Guillermo Garcia-Manero",
year = "2011",
month = "7",
day = "1",
doi = "10.1002/ajh.22031",
language = "English (US)",
volume = "86",
pages = "546--549",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Prediction model for mortality after intracranial hemorrhage in patients with leukemia

AU - Dayyani, Farshid

AU - Mougalian, Sarah Schellhorn

AU - Naqvi, Kiran

AU - Shan, Jianqin

AU - Ravandi, Farhad

AU - Cortes, Jorge

AU - Weinberg, Jeffrey

AU - Jabbour, Elias

AU - Faderl, Stefan

AU - Wierda, William

AU - Thomas, Deborah

AU - O'Brien, Susan

AU - Pierce, Sherry

AU - Kantarjian, Hagop

AU - Garcia-Manero, Guillermo

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Intracranial hemorrhage (ICH) is associated with great morbidity and mortality in patients with acute leukemia. We identified 118 patients with ICH from a total of 2,421 patient with leukemia who were treated at our institution between 2005-2009, and assessed the prognostic factors for mortality in the ICH cohort. Median age at time of ICH was 58 years, 49% were male, and 60% had acute myeloid leukemia. The relative incidence of ICH was highest in patients with chronic myeloid leukemia in blast crisis (12.1%). Mental status changes were the most common symptom which prompted work-up for ICH. Median survival for all patients after onset of ICH was 20 days. In multivariate analyses, four clinical characteristics were identified as independent adverse factors for mortality in patients with ICH: albumin <3.5 g/dL, lactate dehydrogenase (LDH) >835 U/L, age > 60 years, and relapsed disease status. Based on the number of risk factors, mortality after ICH was: 25% (0 risk factor), 47% (1), 78% (2), and >97% (3 or 4). In conclusion, patients with leukemia who develop ICH do not have universally poor outcomes, and a simple scoring system could serve to advise physicians and families of the prognosis and the potential benefit of aggressive treatment options.

AB - Intracranial hemorrhage (ICH) is associated with great morbidity and mortality in patients with acute leukemia. We identified 118 patients with ICH from a total of 2,421 patient with leukemia who were treated at our institution between 2005-2009, and assessed the prognostic factors for mortality in the ICH cohort. Median age at time of ICH was 58 years, 49% were male, and 60% had acute myeloid leukemia. The relative incidence of ICH was highest in patients with chronic myeloid leukemia in blast crisis (12.1%). Mental status changes were the most common symptom which prompted work-up for ICH. Median survival for all patients after onset of ICH was 20 days. In multivariate analyses, four clinical characteristics were identified as independent adverse factors for mortality in patients with ICH: albumin <3.5 g/dL, lactate dehydrogenase (LDH) >835 U/L, age > 60 years, and relapsed disease status. Based on the number of risk factors, mortality after ICH was: 25% (0 risk factor), 47% (1), 78% (2), and >97% (3 or 4). In conclusion, patients with leukemia who develop ICH do not have universally poor outcomes, and a simple scoring system could serve to advise physicians and families of the prognosis and the potential benefit of aggressive treatment options.

UR - http://www.scopus.com/inward/record.url?scp=79959331817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959331817&partnerID=8YFLogxK

U2 - 10.1002/ajh.22031

DO - 10.1002/ajh.22031

M3 - Article

C2 - 21509801

AN - SCOPUS:79959331817

VL - 86

SP - 546

EP - 549

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 7

ER -